These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25707872)

  • 21. [Salsolinol, 3-O-methyl-dopa and homovanillic acid in the cerebrospinal fluid of Parkinson patients].
    Krygowska-Wajs A; Szczudlik A; Antkiewicz-Michaluk L; Romańska I; Vetulani J
    Neurol Neurochir Pol; 1997; 31(5):875-85. PubMed ID: 9513952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis, treatment and gene mutation analysis of the first case with dihydropteridine reductase deficiency in the mainland of China].
    Ye J; Qiu WJ; Han LS; Zhang HW; Zhou JD; Gao XL; Wang Y; Gu XF
    Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):281-5. PubMed ID: 19099731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.
    Lissoni P; Malugani F; Casu M; Bukovec R; Egardi R; Bordin V; Fumagalli E; Mengo S; Gardani G
    Neuro Endocrinol Lett; 2002 Feb; 23(1):61-3. PubMed ID: 11880864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disorders of BH4 metabolism and the treatment of patients with 6-pyruvoyl-tetrahydropterin synthase deficiency in Taiwan.
    Niu DM
    Brain Dev; 2011 Nov; 33(10):847-55. PubMed ID: 21880449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early initiation of L-dopa therapy enables stable development of executive function in tetrahydrobiopterin (BH4) deficiency.
    Tanaka Y; Kato M; Muramatsu T; Saito F; Sato S; Matsuo N; Shintaku H; Okano Y; Kondo H; Nukazawa T
    Dev Med Child Neurol; 2007 May; 49(5):372-6. PubMed ID: 17489812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant phenylketonuria due to defective synthesis of dihydrobiopterin.
    Cohen BE; Szeinberg A; Quint J; Normand M; Blonder J; Peled I
    Isr J Med Sci; 1985 Jun; 21(6):520-5. PubMed ID: 3874852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study of tetrahydrobiopterin responsive phenylalanine hydroxylase deficiency in southern and northern Chinese patients].
    Yang L; Zhang ZX; Ye J; Zhou ZS; Shen M; Han LS; Qiu W; Yu WM; Gu XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):310-3. PubMed ID: 17557244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid synaptic proteins as useful biomarkers in tyrosine hydroxylase deficiency.
    Ortez C; Duarte ST; Ormazábal A; Serrano M; Pérez A; Pons R; Pineda M; Yapici Z; Fernández-Álvarez E; Domingo-Jiménez R; De Castro P; Artuch R; García-Cazorla A
    Mol Genet Metab; 2015 Jan; 114(1):34-40. PubMed ID: 25468651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
    Extein I; Van Woert M; Roth RH; Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women.
    Petraglia F; De Leo V; Sardelli S; Mazzullo G; Gioffrè WR; Genazzani AR; D'Antona N
    Gynecol Obstet Invest; 1987; 23(2):103-9. PubMed ID: 3583091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
    Hietala J; Koulu M; Scheinin M; Syvälahti E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):451-4. PubMed ID: 3935892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat.
    Horowski R; Gräf HJ
    Neuroendocrinology; 1976; 22(3):273-86. PubMed ID: 1028957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A disorder of biogenic amines in dihydropteridine reductase deficiency.
    Butler IJ; Koslow SH; Krumholz A; Holtzman NA; Kaufman S
    Ann Neurol; 1978 Mar; 3(3):224-30. PubMed ID: 27135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA.
    Dominguez-Meijide A; Villar-Cheda B; Garrido-Gil P; Sierrra-Paredes G; Guerra MJ; Labandeira-Garcia JL
    Neuropharmacology; 2014 Jan; 76 Pt A():156-68. PubMed ID: 23973568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on neonatal screening, clinical and gene analysis for tetrahydrobiopterin deficiency in Southern Chinese].
    Ye J; Liu X; Ma X; Huang X; Zhang Y; Gu X; Chen R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):92-5. PubMed ID: 11295124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical phenylketonuria due to biopterin deficiency. Early treatment with tetrahydrobiopterin and neurotransmitter precursors, trials of monotherapy.
    Endres W; Niederwieser A; Curtius HC; Wang M; Ohrt B; Schaub J
    Helv Paediatr Acta; 1982; 37(5):489-98. PubMed ID: 6761317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dihydropteridine reductase deficiency and treatment with tetrahydrobiopterin: a case report.
    Coughlin CR; Hyland K; Randall R; Ficicioglu C
    JIMD Rep; 2013; 10():53-6. PubMed ID: 23430801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of l-dopa administration on the prolactin levels in short-stature subjects].
    Saggese G; Cesaretti G; Carlotti C; Cioni C; Bracaloni C
    Minerva Pediatr; 1992 Mar; 44(3):73-8. PubMed ID: 1518496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.